Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The immunogenicity of breast cancer--molecular subtypes matter.

Literature DB >> 24950977

The immunogenicity of breast cancer--molecular subtypes matter.

C Denkert¹.

Abstract

Entities: Disease

Mesh：

Year: 2014 PMID： 24950977 DOI： 10.1093/annonc/mdu235

Source DB: PubMed Journal: Ann Oncol ISSN： 0923-7534 Impact factor: 32.976

Keyword Cloud
Cited

× No keyword cloud information.

15 in total

Review 1. Tumor-Infiltrating Lymphocytes: A Promising Biomarker in Breast Cancer.

Authors: Barbara Ingold Heppner; Sibylle Loibl; Carsten Denkert
Journal: Breast Care (Basel) Date: 2016-04-26 Impact factor: 2.860

2. Immune checkpoints: Cytotoxic T-lymphocyte antigen 4 and programmed cell death protein 1 in breast cancer surgery.

Authors: Agnieszka Kolacinska; Barbara Cebula-Obrzut; Lukasz Pakula; Justyna Chalubinska-Fendler; Alina Morawiec-Sztandera; Zofia Pawlowska; Izabela Zawlik; Zbigniew Morawiec; Dorota Jesionek-Kupnicka; Piotr Smolewski
Journal: Oncol Lett Date: 2015-06-04 Impact factor: 2.967

3. Regulatory T Cells Support Breast Cancer Progression by Opposing IFN-γ-Dependent Functional Reprogramming of Myeloid Cells.

Authors: Nicholas M Clark; Leandro M Martinez; Steven Murdock; James T deLigio; Amy L Olex; Comfort Effi; Mikhail G Dozmorov; Paula D Bos
Journal: Cell Rep Date: 2020-12-08 Impact factor: 9.423

Review 4. Breast cancer circulating biomarkers: advantages, drawbacks, and new insights.

Authors: Andrea Ravelli; James M Reuben; Francesco Lanza; Simone Anfossi; Maria Rosa Cappelletti; Laura Zanotti; Angela Gobbi; Chiara Senti; Paola Brambilla; Manuela Milani; Daniele Spada; Paolo Pedrazzoli; Massimo Martino; Alberto Bottini; Daniele Generali
Journal: Tumour Biol Date: 2015-08-26

5. Local High-Dose Radiotherapy Induces Systemic Immunomodulating Effects of Potential Therapeutic Relevance in Oligometastatic Breast Cancer.

Authors: Elena Muraro; Carlo Furlan; Michele Avanzo; Debora Martorelli; Elisa Comaro; Aurora Rizzo; Damiana A Fae'; Massimiliano Berretta; Loredana Militello; Alessandro Del Conte; Simon Spazzapan; Riccardo Dolcetti; Marco Trovo'
Journal: Front Immunol Date: 2017-11-06 Impact factor: 7.561

Review 6. Immunotherapy for HER2-positive breast cancer: recent advances and combination therapeutic approaches.

Authors: Nehad M Ayoub; Kamal M Al-Shami; Rami J Yaghan
Journal: Breast Cancer (Dove Med Press) Date: 2019-01-17

7. TILGen: A Program to Investigate Immune Targets in Breast Cancer Patients - First Results on the Influence of Tumor-Infiltrating Lymphocytes.

Authors: Franziska Würfel; Ramona Erber; Hanna Huebner; Alexander Hein; Michael P Lux; Sebastian Jud; Anita Kremer; Hannah Kranich; Andreas Mackensen; Lothar Häberle; Carolin C Hack; Claudia Rauh; Marius Wunderle; Paul Gaß; Shahrooz Rabizadeh; Anna-Lisa Brandl; Hanna Langemann; Bernhard Volz; Naiba Nabieva; Rüdiger Schulz-Wendtland; Diana Dudziak; Matthias W Beckmann; Arndt Hartmann; Peter A Fasching; Matthias Rübner
Journal: Breast Care (Basel) Date: 2018-02-15 Impact factor: 2.860